Detection of specific mRNAs in culture medium conditioned by human tumour cells: Potential for new class of cancer biomarkers in serum

Cancer Genomics and Proteomics

Volumn 2, Issue 1, 2005, Pages 43-52

  O'Driscoll, Lorraine ^a   Kenny, Elaine ^a   Perez De Villarreal, Maider ^a   Clynes, Martin ^a  

^a DUBLIN CITY UNIVERSITY   (Ireland)

Author keywords

Biomarkers; Cancer; Conditioned medium; Genomic profile; Reverse transcriptase polymerase chain reaction; Secreted mRNA; Serum plasma

Indexed keywords

BETA ACTIN; BIOLOGICAL MARKER; CYTOKERATIN 19; DNA TOPOISOMERASE (ATP HYDROLYSING); GLUTATHIONE TRANSFERASE; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1; PROTEIN BCL 2;

ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CELL FREE SYSTEM; CULTURE MEDIUM; GENE AMPLIFICATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LUNG CANCER; NOSE CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SERUM; TUMOR CELL CULTURE;

EID: 20344370268     PISSN: 11096535     EISSN: 17906245     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Jaffer S and Bleiweiss IJ: Beyond hematoxylin and eosin - the role of immunohistochemistry in surgical pathology. Cancer Invest 22: 445-465, 2004.
2. O'Driscoll L, Cronin D, Kennedy SM, Purcell R, Linehan R, Glynn S, Larkin A, McDermott EW, Hill AD, O'Higgins NJ, Parkinson M and Clynes M: Expression and prognostic relevance of Mcl-1 in breast cancer. Anticancer Res 24: 473-482, 2004.
3. Kopreski MS, Benko FA, Kwak LW and Gocke CD: Detection of tumor messenger RNA in the serum of patients with malignant melanoma. Clin Cancer Res 5: 1961-1965, 1999.
4. Rappl G, Hasselmann DO, Robler M, Ugurel S, Tilgen W and Reinhold U: Detection of tumor-associated circulating mRNA in parients with disseminated malignant melanoma. Ann N Y Acad Sci 945: 189-191, 2001.
5. Kopreski MS, Benko FA and Gocke CD: Circulating RNA as a tumour marker. Detection of 5T4 mRNA in breast and lung cancer patient serum. Ann N Y Acad Sci 945: 172-178, 2001.
6. Chen Xq, Bonnefoi H, Pelte M-F, Lyautey J, Lederrey C, Movaeekhi S, Schaeffer P, Mulcahy HE, Meyer P, Stroun M and Anker P: Telomerase RNA as a detection marker in the serum of breast cancer patients. Clin Cancer Res 6: 3823-3826, 2000.
7. Fleischhacker M, Beinert T, Ermitsch M, Seferi D, Possinger K, Engelmann C and Jandrig B: Detection of amplifiable messenger RNA in the serum of patients with lung cancer. Ann N Y Acad Sci 945: 179-188, 2001.
8. Gal S, Fidler C, Lo YMD, Chin K, Moore J, Harris AL and Wainscoat JS: Detection of mammaglobin mRNA in the plasma of breast cancer patients. Ann N Y Acad Sci 945: 192-194, 2001.
9. Silva JM, Dominguez G, Silva J, Garcia JM, Sanchez A, Rodriguez O, Provencio M, Espana P and Bonilla F: Detection of epithelial messenger RNA in the plasma of breast cancer patients is associated with poor prognosis tumor characteristics. Clin Cancer Res 7: 2821-2825, 2001.
10. Ng EKO, Tsui NBY, Lam NYL, Chiu RWK, Yu SCH, Wong SCC, Lo ESF, Rainer TH, Johnson PJ and Lo YMD: Presence of filterable and nonfilterable mRNA in the plasma of cancer patients and healthy individuals. Clin Chem 48: 1212-1217, 2002.
11. Stroun M, Anker P, Beljanski M, Henri J, Lederrey C, Ojha M and Maurice PA: Presence of RNA in the nucleoprotein complex spontaneously released by human lymphocytes and frog auricles in culture. Cancer Res 38: 3546-3554, 1978.
12. Morozkin ES, Laktionov PP, Rykova EY and Vlassov VV: Extracellular nucleic acids in cultures of long-term cultivated eukaryotic cells. Ann N Y Acad Sci 1022: 244-249, 2004.
13. Law E, Gilvarry U, Lynch V, Gregory B, Grant G and Clynes M: Cytogenetic comparison of two poorly differentiated human lung squamous cell carcinoma lines. Cancer Genet Cytogenet 59: 111-118, 1992.
14. Liang Y, Meleady P, Cleary I, McDonnell S, Connolly L and Clynes M: Selection with melphalan or paclitaxel (Taxol) yields variants with different patterns of multidrug resistance, integrin expression and in vitro invasiveness. Eur J Cancer 37: 1041-1052, 2001.
15. Szakacs G, Annereau J-P, Lababidi S, Shankavaram U, Arciello A, Bussey KJ, Reinhold W, Guo Y, Kruh GD, Reimers M, Weinstein JN and Gottesman MM: Predicting drug sensitivity and resistance: profiling ABC transporter genes in cancer cells. Cancer Cell 6: 129-137, 2004.
16. Glynn SA, Gammell P, Heenan M, O'Connor R, Liang Y, Keenan J and Clynes M: A new superinvasive in vitro phenotype induced by selection of human breast carcinoma cells with the chemotherapeutic drugs paclitaxel and doxorubicin. Br J Cancer 91: 1800-1807, 2004.
17. Sisco KL: Is RNA in serum bound to nucleoprotein complexes? Clin Chem 47: 1744-1745, 2001.
18. El-Hefnawy T, Raja S, Kelly L, Bigbee WL, Kirkwood JM, Luketich JD and Godfrey TE: Characterization of amplifiable, circulating RNA in plasma and its potential as a tool for cancer diagnostics. Clin Chem 50: 564-573, 2004.